| What it is | A two‑stage adaptive strategy combining clinic outreach and asynchronous low‑touch text reminders | Clinic outreach followed by low‑touch messages plus synchronous telephone‑based patient navigation | Enhanced outreach (contacting clinic and patient directly) then low‑touch text reminders | Enhanced outreach then high‑touch messaging/navigation combining text reminders and phone‑based support | Typical referral pathway without structured outreach or reminder systems |
|---|
| Role in trial | One of four sequential adaptive strategies within the SMART trial design | One of four sequential adaptive strategies within the SMART trial design | One of four sequential adaptive strategies within the SMART trial design | One of four sequential adaptive strategies within the SMART trial design | Not randomized in the trial; represents usual care without adaptive reach strategies |
|---|
| Primary use or purpose | To increase timely treatment adoption within 90 days of diagnosis | To increase timely treatment adoption within 90 days of diagnosis | To increase timely treatment adoption within 90 days of diagnosis | To increase timely treatment adoption within 90 days of diagnosis | Typical referral without systematic supportive interventions may result in longer delays |
|---|
| How it is given or performed | Clinic staff contact referring clinic, then send asynchronous framed text reminders to patient | Clinic staff contact clinic, then follow up with text reminders plus phone navigation | Pathology team contacts clinic and patient, then uses text message reminders | Pathology team contacts clinic and patient, followed by text reminders and phone‑based navigation | Patients rely on existing referral notifications without structured messaging or navigation |
|---|
| Evidence status | Effectiveness under evaluation; no results published yet | Effectiveness under evaluation; no results published yet | Effectiveness under evaluation; no results published yet | Effectiveness under evaluation; no results published yet | Contextual benchmark based on known delays in existing care systems |
|---|
| Important risks | No intervention risks identified; behavioral strategies are low‑risk | No intervention risks identified; behavioral strategies are low‑risk | No intervention risks identified; behavioral strategies are low‑risk | No intervention risks identified; behavioral strategies are low‑risk | Not an intervention; usual care risks are clinical delay‑related rather than method‑specific |
|---|
| Important limitations | Unknown effectiveness until trial results available; scalability and cost not yet assessed | Unknown effectiveness until trial results available; scalability and resource requirements may be higher | Effectiveness and cost‑effectiveness untested; contacting patients directly may require additional logistics | Unknown results; most complex strategy likely most resource intensive and potentially less scalable | Known delays exist in standard pathway which may result in poor treatment adoption timing |
|---|
| Patient impact | Potential to reduce treatment delays and improve timely access to care; impact not yet measured | Potential to reduce treatment delays and improve timely access to care; impact not yet measured | Potential to reduce treatment delays and improve timely access to care; impact not yet measured | Potential to reduce treatment delays and improve timely access to care; impact not yet measured | Known delays in current care pathways may result in slower access to treatment |
|---|